Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | KDM1A | O60341 | 7/20 | 0.43 |
| ▸ | TNKS | O95271 | 1/20 | 0.36 |
| ▸ | FADS1 | O60427 | 4/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23914279 | 1.00 | ALDH1A1 (0.46) | ALDH1A1CYP2A6KDM1ATNKSFADS1 | |
| SCHEMBL23913791 | 0.88 | TNKS (0.40) | ALDH1A1KDM1ATNKSFADS1CYP19A1 | |
| SCHEMBL23914431 | 0.88 | TNKS (0.40) | ALDH1A1KDM1ATNKSFADS1CYP19A1 | |
| SCHEMBL23914349 | 0.88 | ALDH1A1 (0.39) | ALDH1A1TNKSCYP19A1SLC6A3 | |
| SCHEMBL23914317 | 0.86 | MAOB (0.39) | TNKSFADS1CYP19A1 | |
| SCHEMBL23913941 | 0.86 | CA2 (0.46) | TNKSCYP19A1 | |
| SCHEMBL23913787 | 0.85 | KDM1A (0.46) | ALDH1A1KDM1A | |
| SCHEMBL23914087 | 0.83 | MAOB (0.41) | ALDH1A1TNKSCYP19A1 | |
| SCHEMBL23914439 | 0.83 | MAOB (0.41) | ALDH1A1TNKSCYP19A1 | |
| SCHEMBL23913793 | 0.78 | ACHE (0.44) | ALDH1A1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | ALDH1A1 2164/4885CYP2A6 969/4885KDM1A 3481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.